Document Detail

Acute generalized exanthematous pustulosis induced by bleomycin and confirmed by patch testing.
MedLine Citation:
PMID:  15764037     Owner:  NLM     Status:  MEDLINE    
Acute generalized exanthematous pustulosis is a potentially severe disease caused by drugs in about 90% of cases. To the best of our knowledge, acute generalized exanthematous pustulosis following use of bleomycin has not been previously reported. Here we report a case of acute generalized exanthematous pustulosis induced by bleomycin, which was confirmed by patch testing.
A Altaykan; G Boztepe; G Erkin; O Ozkaya; E Ozden
Related Documents :
25160497 - Oligohydramnios sequence revisited in relationship to arthrogryposis, with distinctive ...
7067237 - A retrospective study of 125 cases of slipped capital femoral epiphysis.
9058367 - Acute metabolic alkalosis in cystic fibrosis: prospective study and review of the liter...
20629127 - Does the historical literature on encephalitis lethargica support a simple (direct) rel...
24397657 - Voices - our fight for front line reinforcements continues, says peter carter.
1478587 - Transverse proximal diaphysial fracture of the fifth metatarsal: a review of 12 cases.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of dermatological treatment     Volume:  15     ISSN:  0954-6634     ISO Abbreviation:  J Dermatolog Treat     Publication Date:  2004 Jul 
Date Detail:
Created Date:  2005-03-14     Completed Date:  2005-04-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8918133     Medline TA:  J Dermatolog Treat     Country:  England    
Other Details:
Languages:  eng     Pagination:  231-4     Citation Subset:  IM    
Department of Dermatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Antineoplastic Agents / adverse effects*
Bleomycin / adverse effects*
Exanthema / chemically induced*,  diagnosis,  pathology
Patch Tests
Skin Diseases, Vesiculobullous / chemically induced*,  diagnosis,  pathology
Reg. No./Substance:
0/Antineoplastic Agents; 11056-06-7/Bleomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Racial differences in the treatment of pigmentation disorders in outpatient settings: analysis of US...
Next Document:  Class I topical corticosteroid use by psoriasis patients in an academic practice.